WordNet

undergo conjugation
unite chemically so that the product is easily broken down into the original compounds
formed by the union of two compounds; "a conjugated protein" (同)conjugated
of an organic compound; containing two or more double bonds each separated from the other by a single bond (同)conjugated
joined together especially in a pair or pairs (同)conjugated, coupled
(of a pinnate leaflet) having only one pair of leaflets
add inflections showing person, number, gender, tense, aspect, etc.; "conjugate the verb"
resembling a horse
hoofed mammals having slender legs and a flat coat with a narrow mane along the back of the neck (同)equid
of or belonging to the family Equidae
a general term for female steroid sex hormones that are secreted by the ovary and responsible for typical female sexual characteristics (同)oestrogen

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 膣萎縮症の治療 treatment of vaginal atrophy
2. 重度または持続性子宮出血のマネージメント managing an episode of severe or prolonged uterine bleeding
3. 骨粗鬆症の予防 prevention of osteoporosis
4. 更年期のほてり menopausal hot flashes
5. ホルモン療法を用いた閉経期症状の治療 treatment of menopausal symptoms with hormone therapy

Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.

Gleason CE1, Dowling NM2, Wharton W3, Manson JE4, Miller VM5, Atwood CS1, Brinton EA6, Cedars MI7, Lobo RA8, Merriam GR9, Neal-Perry G10, Santoro NF11, Taylor HS12, Black DM13, Budoff MJ14, Hodis HN15, Naftolin F16, Harman SM17, Asthana S1.
PLoS medicine.PLoS Med.2015 Jun 2;12(6):e1001833. doi: 10.1371/journal.pmed.1001833. eCollection 2015.
BACKGROUND: Menopausal hormone therapy (MHT) reportedly increases the risk of cognitive decline in women over age 65 y. It is unknown whether similar risks exist for recently postmenopausal women, and whether MHT affects mood in younger women. The ancillary Cognitive and Affective Study (KEEPS-Cog)
PMID 26035291

Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks.

Aedo S1, Cavada G, Blümel JE, Chedraui P, Fica J, Barriga P, Brantes S, Irribarra C, Vallejo M, Campodónico Í.
Menopause (New York, N.Y.).Menopause.2015 May 11. [Epub ahead of print]
OBJECTIVE: This study aims to determine time differences (differences in restricted mean survival times [RMSTs]) in the onset of invasive breast cancer, coronary heart disease, stroke, pulmonary embolism, colorectal cancer, and hip fracture between the placebo group and the conjugated equine estroge
PMID 25968833

17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review.

Mirkin S1, Amadio JM2, Bernick BA2, Pickar JH3, Archer DF4.
Maturitas.Maturitas.2015 May;81(1):28-35. doi: 10.1016/j.maturitas.2015.02.266. Epub 2015 Mar 9.
Several formulations combining estrogens and progestins for hormone therapy (HT) have been approved worldwide for the treatment of menopausal symptoms, yet recent data indicate a decline in their use and an increase in compounded bioidentical HT. Up to now, no single product combining natural 17β-e
PMID 25835751

The analysis of estrone and 17β-estradiol by stir bar sorptive extraction-thermal desorption-gas chromatography/mass spectrometry : Application to urine samples after oral administration of conjugated equine estrogens

STOPFORTH Adriana,BURGER Ben V.,CROUCH Andrew M.,SANDRA Pat
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 856(1), 156-164, 2007-09-01
NAID 10025807583